AC Immune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.

About ACIU

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. 

CEO
Andrea Pfeifer
CEOAndrea Pfeifer
Employees
122
Employees122
Headquarters
Lausanne, Vaud
HeadquartersLausanne, Vaud
Founded
2003
Founded2003
Employees
122
Employees122

ACIU Key Statistics

Market cap
308.88M
Market cap308.88M
Price-Earnings ratio
-3.61
Price-Earnings ratio-3.61
Dividend yield
Dividend yield
Average volume
201.44K
Average volume201.44K
High today
$3.06
High today$3.06
Low today
$2.98
Low today$2.98
Open price
$3.03
Open price$3.03
Volume
35.49K
Volume35.49K
52 Week high
$4.00
52 Week high$4.00
52 Week low
$1.51
52 Week low$1.51

Stock Snapshot

With a market cap of 308.88M, AC Immune(ACIU) trades at $3.04. The stock has a price-to-earnings ratio of -3.61.

As of 2026-05-01, AC Immune(ACIU) stock has fluctuated between $2.98 and $3.06. The current price stands at $3.04, placing the stock +1.8% above today's low and -0.8% off the high.

AC Immune(ACIU) shares are trading with a volume of 35.49K, against a daily average of 201.44K.

During the past year, AC Immune(ACIU) stock moved between $1.51 at its lowest and $4.00 at its peak.

During the past year, AC Immune(ACIU) stock moved between $1.51 at its lowest and $4.00 at its peak.

ACIU News

TipRanks 1d
AC Immune reports Q1 EPS (15c), consensus (14c)

Reports Q1 revenue $1.12M, consensus $263,230. Andrea Pfeifer, CEO of AC Immune (ACIU) SA, commented: “The progress in our collaborations with Takeda and Eli Li...

TipRanks 1d
AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own ACIU. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.